For help on how to get the results you want, see our search tips.
230 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Withdrawn applications Remove Withdrawn applications filter
Withdrawal type
Initial authorisation Remove Initial authorisation filter
-
List item
Withdrawn application: Febseltiq (updated)
infigratinib, date of withdrawal: 11/10/2022, Initial authorisation, Last updated: 30/01/2023 -
List item
Withdrawn application: Hervelous
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Tuznue
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Exkivity
mobocertinib, date of withdrawal: 20/07/2022, Initial authorisation, Last updated: 24/11/2022 -
List item
Withdrawn application: Abylqis
arachis hypogaea extract, date of withdrawal: 17/12/2021, Initial authorisation, Last updated: 23/11/2022 -
List item
Withdrawn application: Sevsury
surufatinib, date of withdrawal: 01/08/2022, Initial authorisation, Last updated: 16/11/2022 -
List item
Withdrawn application: Parsaclisib Incyte Biosciences Distribution B.V.
parsaclisib, date of withdrawal: 27/06/2022, Initial authorisation, Last updated: 08/11/2022 -
List item
Withdrawn application: Dimherity
dimethyl fumarate, date of withdrawal: 22/02/2022, Initial authorisation, Last updated: 03/11/2022 -
List item
Withdrawn application: HemAryo
eptacog alfa (activated), date of withdrawal: 06/05/2022, Initial authorisation, Last updated: 27/09/2022 -
List item
Withdrawn application: Aduhelm
aducanumab, date of withdrawal: 20/04/2022, Initial authorisation, Last updated: 01/08/2022 -
List item
Withdrawn application: Sitoiganap
autologous glioma tumor cell lysates (inactivated), allogeneic glioma tumor cell lysates (inactivated), allogeneic glioma tumor cells (inactivated), autologous glioma tumor cells (inactivated), date of withdrawal: 02/05/2022, Initial authorisation, Last updated: 17/06/2022 -
List item
Withdrawn application: Neffy
epinephrine, date of withdrawal: 04/04/2022, Initial authorisation, Last updated: 20/05/2022 -
List item
Withdrawn application: Zektayos - Hepjuvo
obeticholic acid, date of withdrawal: 09/12/2021, Initial authorisation, Last updated: 08/04/2022 -
List item
Withdrawn application: Livmarli
maralixibat, date of withdrawal: 23/08/2021, Initial authorisation, Last updated: 17/12/2021 -
List item
Withdrawn application: Flynpovi
eflornithine, sulindac, date of withdrawal: 12/10/2021, Initial authorisation, Last updated: 07/12/2021 -
List item
Withdrawn application: Zynyz
retifanlimab, date of withdrawal: 14/10/2021, Initial authorisation, Last updated: 29/11/2021 -
List item
Withdrawn application: Oportuzumab monatox DLRC Pharma Services
oportuzumab monatox, date of withdrawal: 20/08/2021, Initial authorisation, Last updated: 20/10/2021 -
List item
Withdrawn application: Sildenafil FGK
sildenafil, date of withdrawal: 19/07/2021, Initial authorisation, Last updated: 05/10/2021 -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Dexamethasone Taw
dexamethasone phosphate, date of withdrawal: 20/01/2021, Initial authorisation, Last updated: 19/03/2021 -
List item
Withdrawn application: Puldysa
idebenone, date of withdrawal: 28/10/2020, Initial authorisation, Last updated: 18/01/2021 -
List item
Withdrawn application: Upkanz
deferiprone, date of withdrawal: 10/08/2020, Initial authorisation, Last updated: 28/10/2020 -
List item
Withdrawn application: Abilify MyCite
aripiprazole, date of withdrawal: 17/07/2020, Initial authorisation, Last updated: 22/10/2020 -
List item
Withdrawn application: Rayoqta
date of withdrawal: 17/07/2020, Initial authorisation, Last updated: 21/10/2020 -
List item
Withdrawn application: Sondelbay
teriparatide, date of withdrawal: 19/06/2020, Initial authorisation, Last updated: 28/09/2020